Myotonia congenita and myoadenylate deaminase deficiency: Case report

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 2 A, 2003, Pages 262-264

  Scola, Rosana Herminia ^a   Iwamoto, Fabio Massaiti ^a   Camargo, Carlos Henrique ^a   Arruda, Walter Oleschko ^a   Werneck, Lineu Cesar ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Muscle biopsy; Myoadenilate deaminase; Myotonia congenita

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; ENZYME DEFICIENCY; EXERCISE INTOLERANCE; EXERCISE TOLERANCE; HUMAN; MALE; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MYALGIA; MYOPATHY; NEUROPATHY; SCHOOL CHILD; THOMSEN DISEASE;

EID: 0038022783     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2003000200019     Document Type: Article

References (14)

1. Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve 1995;18:239-241.
2. Fishbein WN, Armbrustmacher VW, Griffin JL. Myoadenilate deaminase deficiency: a new disease of muscle. Science 1978;200:545-548.
3. Mercelis R, Martin JJ, de Barsy T, Van den Berghe G. Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies. J Neurol 1987;234:385-389.
4. Morisaki T, Gross M, Morisaki H, Pongratz D, Zöllner N, Holmes EW. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA 1992;89:6457-6461.
5. Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J Inher Metab Dis 1997;20:186-192.
6. Sabina RL, Fishbein WN, Pezeshkpour G, Clarke PRH, Holmes EW. Molecular analysis of the myoadenilate deaminase deficiencies. Neurology 1992;42:170-179.
7. Verzijl HTFM, van Engelen BGM, Luyten JAFM, et al. Genetic characteristics of myoadenilate deaminase deficiency. Ann Neurol 1998;44:140-143.
8. Kar NC, Pearson CM. Muscle adenylate deaminase deficiency. Report of six new cases. Arch Neurol 1981;38:279-281.
9. Bruno C, Minetti C, Shanske S, et al. Combined defects of muscle phosphofructokinase and AMP deaminase in a child with myoglobinuria. Neurology 1998;50:296-298.
10. Ptacek LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482-489.
11. Koty PP, Pegoraro E, Hobson G, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology 1996;47:963-968.
12. Warnstedt M, Sun C, Poser B, et al. The myotonia congenita mutation A331T confers a novel hyperpolarization-activated gate to the muscle chloride channel CIC-1. J Neurosci 2002;22:7462-7470.
13. Gross M, Rotzer E, Kolle P, et al. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. Neuromuscul Disord 2002;12:558-565.
14. Hoffbuhr K, Devaney JM, LaFleur B, et al. MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology 2001;56:1486-1495.